β3-adrenergic receptor Trp64Arg polymorphism does not predict incident CHD or carotid intima-media thickness in a community-based sample of whites: The ARIC study

Human Genetics

Volumn 105, Issue 4, 1999, Pages 314-319

  Morrison, Alanna C ^a   Brancati, Frederick L ^b   Folsom, Aaron R ^c   Smith, Louis ^d   Boerwinkle, Eric ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN; BETA ADRENERGIC RECEPTOR; PRIMER DNA;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; BODY MASS; CAROTID ARTERY; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; INTIMA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; REGRESSION ANALYSIS; AGED; AMINO ACID SUBSTITUTION; ARTERIOSCLEROSIS; CAUCASIAN; COHORT ANALYSIS; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; POINT MUTATION; RISK FACTOR; UNITED STATES;

AGED; ALLELES; AMINO ACID SUBSTITUTION; ARTERIOSCLEROSIS; BASE SEQUENCE; CAROTID ARTERIES; COHORT STUDIES; CORONARY DISEASE; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; RISK FACTORS; UNITED STATES;

EID: 0033211159     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390051107     Document Type: Article

References (43)

1. Allison DB, Heo M, Faith MS, Pietrobelli A (1998) Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 22:559-566
2. American Heart Association (1998) 1999 Heart and stroke statistical update. Dallas, Tex.
3. ARIC Investigators (1989) The atherosclerosis risk in communities (ARIC) study: design and objectives. Am J Epidemiol 129: 687-702
4. Arner P (1995) The β3-adrenergic receptor - a cause and cure of obesity? N Engl J Med 333:382-383
5. Barlow WE (1994) Robust variance estimation for the case-cohort design. Biometrics 50:1064-1072
6. Biery AJ, Ebbesson SO, Shuldiner AR, Boyer BB (1997) The beta(3)-adrenergic receptor Trp64Arg polymorphism and obesity in Alaskan Eskimos. Int J Obes Relat Metab Disord 21:1176-1179
7. Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B (1991) High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities (ARIC) study. J Neuroimaging 1:68-73
8. Buettner R, Schaffler A, Arndt H, Rogler G, Nusser J, Zietz B, Enger I, Hugl S, Cuk A, Scholmerich J, Palitzsch KD (1998) The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endorcrinol Metab 83:2892-2897
9. Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD (1996) Pharmacological characterization of a recently described human beta3-adrenergic receptor mutant. Endocrinology 137:2638-2641
10. Castellano M, Bohm M (1997) The cardiac beta-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension 29:715-722
11. Chagnon Y, Perusse L, Bouchard C (1997) Familial aggregation of obesity, candidate genes and quantitative trait loci. Curr Opin Lipidol 8:205-211
12. Clément K, Vaisse C, Manning BSJ, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberge AD (1995) Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354
13. Colberg SR, Simoneau JA, Thaete FL, Kelley DE (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95:1846-1853
14. Elbein S, Hoffman M, Barrett K, Wegner K, Miles C, Bachman K, Berkowitz D, Shuldiner A, Leppert M, Hasstedt S (1996) Role of the β3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endo Metab 81:4422-4421
15. Emorine LJ, Marullo S, Beind-Sutren M-M, Patey G, Tate K, Delavier-Klutchko C, Strosberge AD (1989) Molecular characterization of the human β3-adrenergic receptor. Science 245: 1118-1121
16. Folsom AR, Eckfeldt JH, Shimon W (1994) Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 25:66-73
17. Friedwald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
18. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T (1998) Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 83:2441-2444
19. Garcia-Rubi E, Starling RD, Tchernof A, Matthews DE, Walston JD, Shuldiner AR, Silver K, Poehlman ET, Calles-Escandon J (1998) Trp64Arg variant of the beta3-adrenoceptor and insulin resistance in obese postmenopausal women. J Clin Endocrinol Metab 83:4002-4005
20. Giacobino JP (1995) Beta3-adrenoceptor: an update. Eur J Endocrinol 132:377-385
21. Gotto AM, Farmer JA (1988) Risk factors for coronary artery disease. Heart Dis 36:1153-1185
22. Higashi K, Ishikawa T, Ito T, Yonemura A, Shige H, Nakamura H (1997) Association of a genetic variation in the β3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophys Res Com 232:728-730
23. Lipworth BJ (1996) Clinical pharmacology of beta3-adrenoceptors. Br J Clin Pharm 42:291-300
24. Lönnqvist F, Thorne A, Nilsell K, Hoffstedt J, Arner P (1995) A pathogenic role of visceral fat β3-adrenoceptors in obesity. J Clin Invest 95:1109-1116
25. McFarlane-Anderson N, Bennett F, Wilks R, Howell S, Newsome C, Cruickshank K, Forrester T (1998) The Trp64Arg mutation of the beta3-adrenergic receptor is associated with hyperglycemia and current body mass index in Jamaican women. Metabolism 47:617-621
26. Mitchell BD, Blangero J, Comuzzie AG, Almasy LA, Shuldiner AR, Silver K, Stern MP, MacCluer JW, Hixson JE (1998) A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 101:584-587
27. Nagele U, Hagele E, Sauer G, Wiedermann E, Lehmann P, Wahlefeld AW, Gruber W (1984) Reagent for the enzymatic determination of serum total triglyceride with improved lipolytic efficiency. J Clin Chem Clin Biochem 22:165-174
28. O'Dell SD, Bolla MK, Miller GJ, Cooper JA, Humphries SE, Day IN (1998) W64R mutation in beta-3-adrenergic receptor gene and weight in a large population sample. Int J Obes Relat Metab Disord 22:377-379
29. Ravussin E, Lillioja S, Knowler WC (1988) Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 318:467-472
30. Riley WA, Barnes R, Bond MG, Evans GW, Chambless L, Heiss G (1991) High resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) study. J Neuroimaging 1:168-172
31. Rissanen J, Kuopusjarvi M, Pihlajamaki J, Sipiläinen R, Heikkinen S, Vanhala M, Kekalainen P, Kuusisto J, Laakso M (1997) The Trp64Arg polymorphism of the β3-adrenergic receptor gene: lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 20:1319-1323
32. Shah BV, Barnwell BG, Bieler GS (1997) SUDAAN user's manual, release 7.5. Research Triangle Institute. Research Triangle Park, N.C.
33. Shiwaku K, Gao TQ, Isobe A, Fukushima T, Yamane Y (1998) A Trp64Arg mutation in the beta3-adrenergic receptor gene is not associated with moderate overweight in Japanese workers. Metabolism 47:1528-1530
34. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1085
35. Silver K, Mitchell BD, Walston J, Sorkin JD, Stern MP, Roth J, Shuldiner AR (1997) Trp64Arg beta 3-adrenergic receptor and obesity in Mexican Americans. Hum Genet 101:306-311
36. 3-adrenoceptor polymorphism with obesity and diabetes: current status. Trends Pharmacol Sci 18:449-454
37. Sun L, Ishibashi S, Osuga J, Harada K, Ohashi K, Gotoda T, Fukuo Y, Yazaki Y, Yamada N (1998) Clinical features associated with the homozygous Trp64Arg mutation of the beta3-adrenergic receptor: no evidence for its association with obesity in Japanese. Arterioscler Thromb Vasc Biol 18:941-946
38. Umekawa T, Yoshida T, Sakane N, Kogure A, Kondo M, Honjyo H (1999) Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes 48:117-120
39. US Department of Health and Human Services, NIH Lung and Blood Institute (1994) Report of the task force on research in epidemiology and prevention of cardiovascular diseases. National Institutes of Health, Bethesda
40. Walston J, Silver K, Borgardus C, Knowler WC, Celi FS, Austin S, Manning BSJ, Strosberg AD, Stern MP, Raben N, Sorkin JD, Roth J, Shuldiner AR (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic receptor gene. N Engl J Med 333:343-347
41. 2+ precipitation. Clin Chem 28:1574
42. Widén E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC (1995) Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351
43. Wilson PWF (1994) Established risk factors and coronary artery disease: the Framingham study. Am J Hypertens 7:7S-12S